EMA 9/21 crossover, 4h, 95% of equity (vol-targeting study: baseline) · XRPUSDT 4h: +357.38%

EMA 9/21 crossover, 4h, 95% of equity (vol-targeting study: baseline) · XRPUSDT 4h: +357.38% — Janorium backtest